Prescribers are not gatekeeping a brand
A licensed provider reviews your submission and, if you meet the criteria, issues a prescription
Application of UPLC-MS/MS to Simultaneously Detect Four Bioactive Compounds in the Tumour-Shrinking Decoction (FM1523) for Uterine Fibroids Treatment
Our warm, supportive, and caring environment yields a positive experience
Women should seek prompt medical advice if they: Have been using retatrutide obtained from an unregulated or online source and experience any adverse symptoms Are pregnant, planning a pregnancy, or breastfeeding and have been offered or are considering retatrutide Have a history of thyroid cancer, pancreatitis, gallbladder disease, or eating disorders and are seeking weight management options Experience unexplained nausea, vomiting, severe abdominal pain, or changes in menstrual cycle while using any GLP-1-based therapy Red flag symptoms requiring urgent medical attention include: Severe or persistent abdominal pain (which may indicate pancreatitis or a gallbladder problem) call 999 or go to A&E if symptoms are severe or accompanied by systemic illness Signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a widespread rash call 999 immediately Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking other glucose-lowering medications Inability to keep fluids down, which may lead to dehydration and kidney problems seek same-day medical advice For women with obesity-related conditions such as PCOS, type 2 diabetes, or cardiovascular risk factors, a structured conversation with a GP or specialist is the safest starting point
Emily Mullin: We know, though, that with any drug, there are differences in response rates, but I think there's been such a spotlight on these anti-obesity drugs, because their results have been really hyped
